Tectonic Therapeutic, Inc.
TECX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $391,991 | $60,285 | $31,055 | $164,988 |
| - Cash | $141,239 | $28,769 | $92,846 | $189,567 |
| + Debt | $3,303 | $4,343 | $5,792 | $1,055 |
| Enterprise Value | $254,055 | $35,859 | -$55,999 | -$23,524 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$56,230 | -$41,193 | -$31,030 | -$8,118 |
| % Margin | – | – | – | – |
| Net Income | -$57,982 | -$42,823 | -$32,180 | -$8,927 |
| % Margin | – | – | – | – |
| EPS Diluted | -3.93 | -11.53 | -29.05 | -33.36 |
| % Growth | 65.9% | 60.3% | 12.9% | – |
| Operating Cash Flow | -$59,080 | -$40,681 | -$97,208 | -$12,454 |
| Capital Expenditures | -$156 | -$279 | -$267 | -$2,122 |
| Free Cash Flow | -$59,236 | -$40,960 | -$97,475 | -$14,576 |